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I-30 September, 1998 
ECSOC-2: 2nd international electronic 
conference on synthetic organic 
chemistry, World Wide Web. 
Contact: Esteban Pombo-Villar, 
ECSOC-2 Chairman, Preclinical 
Research, Novartis Pharma AG, 4002 
Basel, Switzerland. 
Tel: +41 61 324 9865 
Fax: +41 61 324 9794 
e-mail: esteban.pombo@pharma. 
novartiscom 
http://www.mdpi.org/ecsoc-2.htm 
15-20 September, 1998 
The first international conference on 
the inhibitors of protein kinases, 
Warsaw, Poland. 
Contact: Barbara Kleyny, Interdisciplinary 
centre for mathematical and 
computational modelling (ICM), 
University of Warsaw, Pawinskiego 5a, 
02-106, Warsaw, Poland. 
Tel: + 48 22 874 9115 
Fax: + 44 22 874 9200 
e-mail: ipk98@icm.edu.p1 
http://www.icm.edu.pl/ipk98 
2 l-23 September, 1998 
Biochemical society meeting, 
Leicester, UK. 
Contact: Katie Steptoe, The Meetings 
Office - Biochemical Society, 59 
Portland Place, London WlN 3AJ, UK. 
Tel:+441716377626 
e-mail: meetings@biochemsoc.org.uk 
2 l-24 September, 1998 
4th Annual conference and exhibition 
of the society for biomolecular 
screening, Baltimore, MD, USA. 
Contact: Christine Giordano, Society 
for Biomolecular Screening, 36 
Tamarack Avenue, Suite 348, 
Danbury, CT 06811, USA. 
Tel: +l 203 743-1336 
Fax: +l 203 748-7557 
e-mail: c-giordano@prodigy.com 
http://sbsonline.org 
24-28 September, 1998 
AACR Special conference in cancer 
research: cellular targets of viral 
carcinogenesis, Dana Point, CA, USA. 
Contact: California American 
Association for Cancer Research, Public 
Ledger Building, Suite 826, 150 South 
Independence Mall West, Philadelphia, 
PA 19106-3483, USA. 
Tel: +1 215 440 9300 
Fax: +l 215 440 9313 
e-mail: aacr@aacr.org 
http://www.aacr.org 
26 September - 1 October, 1998 
European research conferences - 
membrane dynamics in exocytosis: 
molecular mechanisms, Giens, 
France. 
Contact: J Hendovic, European Science 
Foundation, 1 quai Lezay-Marnesia, 
67080 Strasbourg Cedex, France. 
Fax: + 33 388 3669 87 
e-mail: euresco@esf.org 
http://www.esf.org/euresco 
4-7 October, 1998 
Structure-based functional genomics, 
Avalon, NJ, USA. 
Contact: Becky Watson, Center for 
Advanced Biotechnology & Medicine, 
Rutgers University, 679 Hoes Lane, 
Piscataway, NJ 08854-5638, USA. 
Tel: +l 732 235 5321 
Fax: +l 732 235 5321 
e-mail: watson@cabm.rutgers.edu, 
http://www.cabm.rutgers.edu/ 
bioinformatics-meeting/ 
4-9 October, 1998 
3rd Australian peptide conference: 
from discovery to therapeutics, 
Queensland, Australia. 
Contact: Dr AI Smith, Baker Medical 
Research Institute, PO Box 348, 
Prahran, Victoria 3181, Australia, 
Tel: +613 9522 4333 
Fax: +613 9521 1362 
e-mail: Ian.Smith@Baker.edu.au 
http://www.hfi.unimelb.edu.au/ 
peptideozl 
5-7 October, 1998 
G Protein-coupled receptors IV, 
Orlando, FL, USA. 
Contact: BC USA Conferences, Inc., 
225 Turnpike Road, Southborough, MA 
01772-1749, USA. 
Tel: +l 508 481 6400 
Fax: +I 508 481 7911 
e-mail: inq@ibcusa.com 
http://www.ibcusa.com/conf/gproteinl 
index.html 
6-7 October, 1998 
IBC’s 6th Annual conference on 
transcription regulation of clinically 
relevant genes, La Jolla, CA, USA. 
Contact: IBC USA Conferences, Inc., 
225 Turnpike Road, Southborough, MA 
01772-1749, USA. 
Tel: +l 508 481 6400 
Fax: +l 508 481 7911 
e-mail: inq@ibcusa.com 
7-9 October, 1998 
Strategies and techniques for 
identification of novel bioactive 
compounds, Zurich, Switzerland. 
Contact: Cambridge Healthtech Institute, 
1037 Chestnut Street, Newton Upper 
Falls, MA 02464, USA. 
Tel: +1617 630 1300 
Fax: +1617 630 1325 
8-9 October, 1998 
Nuclear hormone receptors: 
transcriptional mechanisms and 
novel targets, Philadelphia, USA. 
Contact: NMHCC, Inc., PO Box 
102713, Atlanta, GA 303682713, USA. 
Tel: +l 941 365 4471 
Fax: +1941 365 0157 
R240 
A selection of interesting papers 
published last month in Chemistry 
& Biology’s sister journals, Current 
Biology, Folding & Design and 
Structure, chosen and summarized 
by the staff of Chemistry & Biology. 
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0 RNA unwinding in U4/U6 snRNPs 
requires ATP hydrolysis and the 
DEIH-box splicing factor Brr2. 
Pratima L Raghunathan and 
Christine Guthrie (1998). Cm Biol, 
8,847-855. 
The dynamic rearrangements of RNA 
structure that occur during pre-mRNA 
splicing are thought to be mediated by 
members of the DExD/H-box family of 
RNA-dependent ATPases. Although 
three DExD/H-box splicing factors 
have recently been shown to unwind 
synthetic RNA duplexes in purified 
systems, in no case has the natural 
biological substrate been identified. A 
duplex RNA target of particular 
interest is the extensive base-pairing 
interaction between U4 and U6 small 
nuclear RNAs. Because these helices 
must be disrupted to activate the 
spliceosome for catalysis, this 
rearrangement is believed to be tightly 
regulated in viva. The authors have 
immunopurified BrrZ, a DEIH-box 
ATPase, in a native complex containing 
Ul, LJZ, U5 and duplex U4/U6 small 
nuclear ribonucleoprotein particles 
(snRNPs). Addition of hydrolyzable 
ATP to this complex results in the 
disruption of U4/U6 base-pairing, and 
the release of free U4 and U6 snRNPs. 
A mutation in the helicase-like domain 
of Brr2 (6rr2-I) prevents these RNA 
rearrangements. Notably, U4/U6 
dissociation and release occur in the 
absence of exogenously added pre- 
mRNA. Disruption of U4/U6 base- 
pairing in native snRNPs requires ATP 
hydrolysis and Brr2. This is the first 
assignment of a DExD/H-box splicing 
factor to a specific biological unwinding 
event. The unwinding function of Brr2 
can be antagonized by the annealing 
activity of Prp24. The existence of a 
dynamic cycle, uncoupled from 
splicing, that interconverts free and 
base-paired U4/U6 snRNP is proposed. 
29 June 1998, Research Paper, Current 
Biology 
0 The exchange factor Ras-GRF2 
activates Ras-dependent and Rac- 
dependent mitogen-activated 
protein kinase pathways. Wing-Tze 
Fan, C Anne Koch, Carmen L de 
Hoog, Neil P Fam and Michael F 
Moran (1998). Curr. Biol. 8, 
935-938. 
Ras and Rat are membrane-associated 
GTPases that function as molecular 
switches activating intracellular 
mitogen-activated protein kinase 
(MAPK) cascades and other effector 
pathways in response to extracellular 
signals. Activation of Ras and Rat into 
their GTP-bound conformations is 
directly controlled by specific guanine- 
I 1 
RZ3 Racl 
GST Cdc42 RhoA 
nucleotide exchange factors (GEFs), 
which catalyze GDP release. Several 
Ras-specific GEFs that are related to 
the budding yeast protein Cd&p have 
been described, whereas GEFs for Rac- 
related GTPases contain a region that is 
homologous to the oncoprotein Dbl. 
The Ras-GRFl and Ras-GRFZ 
proteins, which couple Ras activation to 
serpentine receptors and calcium 
signals, contain both Cdc25 and Dbl 
homology (DH) regions. Here, the 
authors demonstrate that Ras-GRF2 is a 
bifunctional signaling protein that is 
able to bind and activate Ras and Rat, 
and thereby coordinate the activation of 
the extracellular-signal-regulated kinase 
(ERK) and stress-activated protein 
kinase (SAPK) pathways. 
27 July 1998, Brief Communication, 
Currenf Biology 
0 Parallel evolution of CCR5-null 
phenotypes in humans and in a 
natural host of simian 
immunodeficiency viruses. Emil 
Palacios, Laura Digilio, Harold M 
McClure, Zhiwei Chen, Preston A 
Marx, Mark A Goldsmith and Robert 
M Grant (1998). Cm Biol. 8, 
943-946. 
The C-C chemokine receptor CCRS in 
humans and rhesus macaques (Macaca 
mulatta) serves as the primary 
coreceptor for cellular entry by 
macrophage-tropic strains of human 
immunodeficiency virus type 1 (HIV-l) 
and all reported strains of simian 
immunodeficiency virus (SIV). 
Humans homozygous for a 32 bp 
deletion allele of CCR5, resulting in a 
null phenotype, are highly resistant to 
infection by HIV-l, prompting 
development of therapies and vaccines 
targeting CCR.5. The authors now 
report a novel deletion allele of CCRS, 
with an allele frequency of 0.04, in 
sooty mangabey monkeys (Cercoce&s 
torguatus atys), a natural host of SIV 
(SIVsmm). The mutant protein was not 
expressed at the cell surface and 
accordingly did not function as a viral 
coreceptor. Primary activated 
lymphocytes from mangabeys 
heterozygous for the deletion allele 
expressed significantly less CCRS on 
